PER
Click for more information
4.94% 8.5¢ percheron therapeutics limited

FDA approves Sareptas Srp901 for the whole population, page-9

  1. itsagas
    13,075 Posts.
    lightbulb Created with Sketch. 1362
    clock Created with Sketch.
    21/06/24
    12:18
    Post #: 74424040
    correct
    One has to ask the question ?
    If Per don’t meet the Primary PUL2.0 endpoints
    but show the secondary muscle function improvement .. is that enough to get FDA approval?

    We know the boys on trial now are pressing on past the 6 month dosing is an indication that it’s showing benefits .
    all good
    PER Price at posting: 8.6¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢ 		Change
0.004(4.94%) 		Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $46.54K 563.7K

Buyers (Bids)

No. Vol. Price($)
2 164616 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 100110 1
View Market Depth
Last trade - 15.55pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.